J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edelstein, C.
Right arrow Articles by Scanu, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edelstein, C.
Right arrow Articles by Scanu, A. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 37, 1786-1801, Copyright © 1996 by Lipid Research, Inc.


ARTICLES

Functional and metabolic differences between elastase-generated fragments of human lipoprotein[a] and apolipoprotein[a]

C Edelstein, JA Italia, O Klezovitch and AM Scanu
Department of Medicine, University of Chicago, IL 60637, USA.

We have previously shown that a functional free apolipoprotein[a] (apo[a]) can be isolated from its parent lipoprotein[a] (Lp[a]) by a mild reductive procedure. To shed further light on the properties of Lp[a] and apo[a] we subjected them to a limited proteolysis by porcine pancreatic elastase. This enzyme cleaved both at the Ile3520-Leu3521 bond in the linker between kringles IV-4 and IV-5 of apo[a] generating two fragments F1 and F2. In contrast to F1, which represented the N- terminal portion of apo[a] and was functionally inert, F2, representing the C-terminal domain, bound to lysine-Sepharose, fibrinogen, and fibronectin and formed a miniLp[a] particle when incubated with LDL. The proteolytic pattern by pancreatic elastase was also exhibited by human leukocyte elastase. F1, injected intravenously into normal mice, was rapidly cleared (Ty2, 2.9 h) and after 1 h fragments in the size range of 100-33 kDa were observed in the urine. In turn, F2 had a longer residence time (Ty2, 5 h) and was excreted in the urine only after 5 h as fragments of 70-45 kDa. Fragments in the same size range as found after F1 injection were also present in the urine after injection of apo[a] or Lp[a]. Moreover, apo[a] fragments of the size seen in mouse urine were spontaneously present in normal human urine and appeared derived from larger apo[a] fragments in the plasma. Our results indicate that enzymes of the elastase family cleave human apo[a] in vitro into two main fragments that differ in structural and functional properties and metabolic behavior. The comparable size of apo[a] fragments observed in the urine of humans and injected mice invites the speculation that enzymes of the elastase family may play a role in the biology of Lp[a] in vivo.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
C. Edelstein, M. Yousef, and A. M. Scanu
Elements in the C terminus of apolipoprotein [a] responsible for the binding to the tenth type III module of human fibronectin
J. Lipid Res., December 1, 2005; 46(12): 2673 - 2680.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. M. Devlin, S.-J. Lee, G. Kuriakose, C. Spencer, L. Becker, I. Grosskopf, C. Ko, L.-S. Huang, M. L. Koschinsky, A. D. Cooper, et al.
An Apolipoprotein(a) Peptide Delays Chylomicron Remnant Clearance and Increases Plasma Remnant Lipoproteins and Atherosclerosis In Vivo
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1704 - 1710.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Berglund and R. Ramakrishnan
Lipoprotein(a): An Elusive Cardiovascular Risk Factor
Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2219 - 2226.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Edelstein, D. Pfaffinger, J. Hinman, E. Miller, G. Lipkind, S. Tsimikas, C. Bergmark, G. S. Getz, J. L. Witztum, and A. M. Scanu
Lysine-Phosphatidylcholine Adducts in Kringle V Impart Unique Immunological and Potential Pro-inflammatory Properties to Human Apolipoprotein(a)
J. Biol. Chem., December 26, 2003; 278(52): 52841 - 52847.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-S. Kim, J.-H. Chang, H.-K. Yu, J.-H. Ahn, J.-S. Yum, S.-K. Lee, K.-H. Jung, D.-H. Park, Y. Yoon, S.-M. Byun, et al.
Inhibition of Angiogenesis and Angiogenesis-dependent Tumor Growth by the Cryptic Kringle Fragments of Human Apolipoprotein(a)
J. Biol. Chem., August 1, 2003; 278(31): 29000 - 29008.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Klezovitch, C. Edelstein, and A. M. Scanu
Stimulation of Interleukin-8 Production in Human THP-1 Macrophages by Apolipoprotein(a). EVIDENCE FOR A CRITICAL INVOLVEMENT OF ELEMENTS IN ITS C-TERMINAL DOMAIN
J. Biol. Chem., December 7, 2001; 276(50): 46864 - 46869.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. M. Caplice, C. Panetta, T. E. Peterson, L. S. Kleppe, C. S. Mueske, G. M. Kostner, G. J. Broze Jr, and R. D. Simari
Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis
Blood, November 15, 2001; 98(10): 2980 - 2987.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. Edelstein, K. Nakajima, D. Pfaffinger, and A. M. Scanu
Oxidative events cause degradation of apoB-100 but not of apo[a] and facilitate enzymatic cleavage of both proteins
J. Lipid Res., October 1, 2001; 42(10): 1664 - 1670.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Nakajima, J. Hinman, D. Pfaffinger, C. Edelstein, and A. M. Scanu
Changes in Plasma Triglyceride Levels Shift Lipoprotein(a) Density in Parallel With That of LDL Independently of Apolipoprotein(a) Size
Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1238 - 1243.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Bdeir, W. Cane, G. Canziani, I. Chaiken, J. Weisel, M. L. Koschinsky, R. M. Lawn, P. G. Bannerman, B. S. Sachais, A. Kuo, et al.
Defensin Promotes the Binding of Lipoprotein(a) to Vascular Matrix
Blood, September 15, 1999; 94(6): 2007 - 2019.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Edelstein, S. D. Shapiro, O. Klezovitch, and A. M. Scanu
Macrophage Metalloelastase, MMP-12, Cleaves Human Apolipoprotein(a) in the Linker Region between Kringles IV-4 and IV-5. POTENTIAL RELEVANCE TO LIPOPROTEIN(a) BIOLOGY
J. Biol. Chem., April 9, 1999; 274(15): 10019 - 10023.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. M. Fless, E. W. Kirk, O. Klezovitch, J. Y. Santiago, C. Edelstein, J. Hoover-Plow, and A. M. Scanu
Effect of phospholipase A2 digestion on the conformation and lysine/fibrinogen binding properties of human lipoprotein[a]
J. Lipid Res., April 1, 1999; 40(4): 583 - 592.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. Mooser, F. Tinguely, P. Fontana, V. Lenain, M. Vaglio, P. Ruchat, L. K. von Segesser, S. M. Marcovina, M. Markert, R. Darioli, et al.
Effect of Cardiopulmonary Bypass and Heparin on Plasma Levels of Lp(a) and Apo(a) Fragments
Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 1060 - 1065.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Klezovitch, C. Edelstein, L. Zhu, and A. M. Scanu
Apolipoprotein(a) Binds via Its C-terminal Domain to the Protein Core of the Proteoglycan Decorin. IMPLICATIONS FOR THE RETENTION OF LIPOPROTEIN(a) IN ATHEROSCLEROTIC LESIONS
J. Biol. Chem., September 11, 1998; 273(37): 23856 - 23865.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. B. Nielsen, K. Juul, and B. G. Nordestgaard
Increased Degradation of Lipoprotein(a) in Atherosclerotic Compared With Nonlesioned Aortic Intima–Inner Media of Rabbits : In Vivo Evidence That Lipoprotein(a) May Contribute to Foam Cell Formation
Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 641 - 649.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Edelstein, J. A. Italia, and A. M. Scanu
Polymorphonuclear Cells Isolated from Human Peripheral Blood Cleave Lipoprotein(a) and Apolipoprotein(a) at Multiple Interkringle Sites via the Enzyme Elastase. GENERATION OF mini-Lp(a) PARTICLES AND apo(a) FRAGMENTS
J. Biol. Chem., April 25, 1997; 272(17): 11079 - 11087.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Garner, A. H. Merry, L. Royle, D. J. Harvey, P. M. Rudd, and J. Thillet
Structural Elucidation of the N- and O-Glycans of Human Apolipoprotein(a). ROLE OF O-GLYCANS IN CONFERRING PROTEASE RESISTANCE
J. Biol. Chem., June 15, 2001; 276(25): 22200 - 22208.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.